サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1790576

経鼻ドラッグデリバリーシステムの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Intranasal Drug Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 100 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
経鼻ドラッグデリバリーシステムの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年08月15日
発行: QYResearch
ページ情報: 英文 100 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、経鼻ドラッグデリバリーシステム (Intranasal Drug Delivery System) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • 経鼻ドラッグデリバリーシステム 製品範囲
  • 経鼻ドラッグデリバリーシステム タイプ別
    • 世界の経鼻ドラッグデリバリーシステム 販売：タイプ別 (2020 & 2024 & 2031)
    • Nasal Drops
    • Nasal Sprays
    • Nasal Gels
    • Nasal Suspensions and Emulsion
    • Nasal Powders
  • 経鼻ドラッグデリバリーシステム 用途別
    • 世界の経鼻ドラッグデリバリーシステム 売上 比較：用途別 (2020 & 2024 & 2031)
    • Hospital
    • Clinic
    • Home Care
    • Others
  • 世界の経鼻ドラッグデリバリーシステム 市場 推定および予測 (2020-2031)
    • 世界の経鼻ドラッグデリバリーシステム 市場規模 in 価格 成長率 (2020-2031)
    • Global Intranasal Drug Delivery System Market Size in Volume Growth Rate (2020-2031)
    • Global Intranasal Drug Delivery System Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界の経鼻ドラッグデリバリーシステム 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界の経鼻ドラッグデリバリーシステム 過去の市場分析：地域別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステムの販売市場シェア 地域別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステムの収益市場シェア 地域別 (2020-2025)
  • 世界の経鼻ドラッグデリバリーシステム 市場 推定および予測 地域別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステム 売上予測・予想 地域別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米の経鼻ドラッグデリバリーシステム 市場規模および予測 (2020-2031)
    • 欧州の経鼻ドラッグデリバリーシステム 市場規模および予測 (2020-2031)
    • 中国の経鼻ドラッグデリバリーシステム 市場規模および予測 (2020-2031)
    • 日本の経鼻ドラッグデリバリーシステム 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界の経鼻ドラッグデリバリーシステムの過去の市場概要：タイプ別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 販売：タイプ別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 収益：タイプ別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 価格：タイプ別 (2020-2025)
  • 世界の経鼻ドラッグデリバリーシステムの市場 推定および予測：タイプ別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの販売予測：タイプ別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの収益予測：タイプ別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの価格予測：タイプ別 (2026-2031)
  • 各種タイプ 経鼻ドラッグデリバリーシステム 代表的な企業

第4章 世界の市場規模：用途別

  • 世界の経鼻ドラッグデリバリーシステムの過去の市場概要：用途別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 販売：用途別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 収益：用途別 (2020-2025)
    • 世界の経鼻ドラッグデリバリーシステム 価格：用途別 (2020-2025)
  • 世界の経鼻ドラッグデリバリーシステム 市場 推定および予測：用途別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの販売予測：用途別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの収益予測：用途別 (2026-2031)
    • 世界の経鼻ドラッグデリバリーシステムの価格予測：用途別 (2026-2031)
  • 新たな成長源 経鼻ドラッグデリバリーシステム アプリケーション

第5章 競合他社の状況

  • 世界の経鼻ドラッグデリバリーシステム 売上 ：競合別 (2020-2025)
  • 世界の経鼻ドラッグデリバリーシステムの上位企業：収益別 (2020-2025)
  • 世界の経鼻ドラッグデリバリーシステムの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース 経鼻ドラッグデリバリーシステム 2024年)
  • 世界の経鼻ドラッグデリバリーシステム 企業別平均価格 (2020-2025)
  • 世界の主要メーカー 経鼻ドラッグデリバリーシステム, 製造拠点 & 本社
  • 世界の主要メーカー 経鼻ドラッグデリバリーシステム, 製品の種類・用途
  • 世界の主要メーカー 経鼻ドラッグデリバリーシステム, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米の経鼻ドラッグデリバリーシステム 売上：企業別
    • 北米の経鼻ドラッグデリバリーシステム 売上 内訳 タイプ別 (2020-2025)
    • 北米の経鼻ドラッグデリバリーシステム 売上構成比：用途別 (2020-2025)
    • 北米の経鼻ドラッグデリバリーシステム 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州の経鼻ドラッグデリバリーシステム 売上：企業別
    • 欧州の経鼻ドラッグデリバリーシステム 売上 内訳 タイプ別 (2020-2025)
    • 欧州の経鼻ドラッグデリバリーシステム 売上構成比：用途別 (2020-2025)
    • 欧州の経鼻ドラッグデリバリーシステム 主要顧客
    • 欧州の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国の経鼻ドラッグデリバリーシステム 売上：企業別
    • 中国の経鼻ドラッグデリバリーシステム 売上 内訳 タイプ別 (2020-2025)
    • 中国の経鼻ドラッグデリバリーシステム 売上構成比：用途別 (2020-2025)
    • 中国の経鼻ドラッグデリバリーシステム 主要顧客
    • 中国の市場 トレンドと機会
  • 日本の市場: 参入企業、セグメント、下流、主要顧客
    • 日本の経鼻ドラッグデリバリーシステム 売上：企業別
    • 日本の経鼻ドラッグデリバリーシステム 売上 内訳 タイプ別 (2020-2025)
    • 日本の経鼻ドラッグデリバリーシステム 売上構成比：用途別 (2020-2025)
    • 日本の経鼻ドラッグデリバリーシステム 主要顧客
    • 日本の市場 トレンドと機会

第7章 企業概要と主要企業

  • Aptar Pharma
  • Nemera
  • Teleflex
  • Bio-Legacy Evaluative Group
  • Zeteo Medical
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Aegis Therapeutics LLC
  • H&T Presspart Manufacturing Ltd.
  • AstraZeneca Plc
  • Becton
  • BD
  • Novartis AG
  • Vectura Group Plc

第8章 経鼻ドラッグデリバリーシステム 製造コスト分析

  • 経鼻ドラッグデリバリーシステム 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： 経鼻ドラッグデリバリーシステム
  • 経鼻ドラッグデリバリーシステム 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • 経鼻ドラッグデリバリーシステム 販売代理店一覧
  • 経鼻ドラッグデリバリーシステム 顧客

第10章 経鼻ドラッグデリバリーシステム 市場動向

  • 経鼻ドラッグデリバリーシステム 業界動向
  • 経鼻ドラッグデリバリーシステム 市場の促進要因
  • 経鼻ドラッグデリバリーシステム 市場の課題
  • 経鼻ドラッグデリバリーシステム 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Intranasal Drug Delivery System Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Intranasal Drug Delivery System Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Intranasal Drug Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Intranasal Drug Delivery System Sales (K Units) by Region (2020-2025)

Table 5. Global Intranasal Drug Delivery System Sales Market Share by Region (2020-2025)

Table 6. Global Intranasal Drug Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Intranasal Drug Delivery System Revenue Share by Region (2020-2025)

Table 8. Global Intranasal Drug Delivery System Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Intranasal Drug Delivery System Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Intranasal Drug Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Intranasal Drug Delivery System Revenue Share Forecast by Region (2026-2031)

Table 12. Global Intranasal Drug Delivery System Sales by Type (K Units) & (2020-2025)

Table 13. Global Intranasal Drug Delivery System Sales Share by Type (2020-2025)

Table 14. Global Intranasal Drug Delivery System Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Intranasal Drug Delivery System Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Intranasal Drug Delivery System Sales by Type (K Units) & (2026-2031)

Table 17. Global Intranasal Drug Delivery System Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Intranasal Drug Delivery System Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Intranasal Drug Delivery System Sales by Application (K Units) & (2020-2025)

Table 21. Global Intranasal Drug Delivery System Sales Share by Application (2020-2025)

Table 22. Global Intranasal Drug Delivery System Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Intranasal Drug Delivery System Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Intranasal Drug Delivery System Sales by Application (K Units) & (2026-2031)

Table 25. Global Intranasal Drug Delivery System Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Intranasal Drug Delivery System Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Intranasal Drug Delivery System Application

Table 28. Global Intranasal Drug Delivery System Sales by Company (K Units) & (2020-2025)

Table 29. Global Intranasal Drug Delivery System Sales Share by Company (2020-2025)

Table 30. Global Intranasal Drug Delivery System Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Intranasal Drug Delivery System Revenue Share by Company (2020-2025)

Table 32. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2024)

Table 33. Global Market Intranasal Drug Delivery System Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Intranasal Drug Delivery System, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Intranasal Drug Delivery System, Product Type & Application

Table 36. Global Key Manufacturers of Intranasal Drug Delivery System, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Intranasal Drug Delivery System Sales by Company (2020-2025) & (K Units)

Table 39. North America Intranasal Drug Delivery System Sales Market Share by Company (2020-2025)

Table 40. North America Intranasal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Intranasal Drug Delivery System Revenue Market Share by Company (2020-2025)

Table 42. North America Intranasal Drug Delivery System Sales by Type (2020-2025) & (K Units)

Table 43. North America Intranasal Drug Delivery System Sales Market Share by Type (2020-2025)

Table 44. North America Intranasal Drug Delivery System Sales by Application (2020-2025) & (K Units)

Table 45. North America Intranasal Drug Delivery System Sales Market Share by Application (2020-2025)

Table 46. Europe Intranasal Drug Delivery System Sales by Company (2020-2025) & (K Units)

Table 47. Europe Intranasal Drug Delivery System Sales Market Share by Company (2020-2025)

Table 48. Europe Intranasal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Intranasal Drug Delivery System Revenue Market Share by Company (2020-2025)

Table 50. Europe Intranasal Drug Delivery System Sales by Type (2020-2025) & (K Units)

Table 51. Europe Intranasal Drug Delivery System Sales Market Share by Type (2020-2025)

Table 52. Europe Intranasal Drug Delivery System Sales by Application (2020-2025) & (K Units)

Table 53. Europe Intranasal Drug Delivery System Sales Market Share by Application (2020-2025)

Table 54. China Intranasal Drug Delivery System Sales by Company (2020-2025) & (K Units)

Table 55. China Intranasal Drug Delivery System Sales Market Share by Company (2020-2025)

Table 56. China Intranasal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Intranasal Drug Delivery System Revenue Market Share by Company (2020-2025)

Table 58. China Intranasal Drug Delivery System Sales by Type (2020-2025) & (K Units)

Table 59. China Intranasal Drug Delivery System Sales Market Share by Type (2020-2025)

Table 60. China Intranasal Drug Delivery System Sales by Application (2020-2025) & (K Units)

Table 61. China Intranasal Drug Delivery System Sales Market Share by Application (2020-2025)

Table 62. Japan Intranasal Drug Delivery System Sales by Company (2020-2025) & (K Units)

Table 63. Japan Intranasal Drug Delivery System Sales Market Share by Company (2020-2025)

Table 64. Japan Intranasal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Intranasal Drug Delivery System Revenue Market Share by Company (2020-2025)

Table 66. Japan Intranasal Drug Delivery System Sales by Type (2020-2025) & (K Units)

Table 67. Japan Intranasal Drug Delivery System Sales Market Share by Type (2020-2025)

Table 68. Japan Intranasal Drug Delivery System Sales by Application (2020-2025) & (K Units)

Table 69. Japan Intranasal Drug Delivery System Sales Market Share by Application (2020-2025)

Table 70. Aptar Pharma Company Information

Table 71. Aptar Pharma Description and Business Overview

Table 72. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Aptar Pharma Intranasal Drug Delivery System Product

Table 74. Aptar Pharma Recent Development

Table 75. Nemera Company Information

Table 76. Nemera Description and Business Overview

Table 77. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Nemera Intranasal Drug Delivery System Product

Table 79. Nemera Recent Development

Table 80. Teleflex Company Information

Table 81. Teleflex Description and Business Overview

Table 82. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Teleflex Intranasal Drug Delivery System Product

Table 84. Teleflex Recent Development

Table 85. Bio-Legacy Evaluative Group Company Information

Table 86. Bio-Legacy Evaluative Group Description and Business Overview

Table 87. Bio-Legacy Evaluative Group Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Bio-Legacy Evaluative Group Intranasal Drug Delivery System Product

Table 89. Bio-Legacy Evaluative Group Recent Development

Table 90. Zeteo Medical Company Information

Table 91. Zeteo Medical Description and Business Overview

Table 92. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Zeteo Medical Intranasal Drug Delivery System Product

Table 94. Zeteo Medical Recent Development

Table 95. Johnson & Johnson Company Information

Table 96. Johnson & Johnson Description and Business Overview

Table 97. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Johnson & Johnson Intranasal Drug Delivery System Product

Table 99. Johnson & Johnson Recent Development

Table 100. GlaxoSmithKline Plc Company Information

Table 101. GlaxoSmithKline Plc Description and Business Overview

Table 102. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. GlaxoSmithKline Plc Intranasal Drug Delivery System Product

Table 104. GlaxoSmithKline Plc Recent Development

Table 105. Aegis Therapeutics LLC Company Information

Table 106. Aegis Therapeutics LLC Description and Business Overview

Table 107. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Aegis Therapeutics LLC Intranasal Drug Delivery System Product

Table 109. Aegis Therapeutics LLC Recent Development

Table 110. H&T Presspart Manufacturing Ltd. Company Information

Table 111. H&T Presspart Manufacturing Ltd. Description and Business Overview

Table 112. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product

Table 114. H&T Presspart Manufacturing Ltd. Recent Development

Table 115. AstraZeneca Plc Company Information

Table 116. AstraZeneca Plc Description and Business Overview

Table 117. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. AstraZeneca Plc Intranasal Drug Delivery System Product

Table 119. AstraZeneca Plc Recent Development

Table 120. Becton Company Information

Table 121. Becton Description and Business Overview

Table 122. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Becton Intranasal Drug Delivery System Product

Table 124. Becton Recent Development

Table 125. BD Company Information

Table 126. BD Description and Business Overview

Table 127. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. BD Intranasal Drug Delivery System Product

Table 129. BD Recent Development

Table 130. Novartis AG Company Information

Table 131. Novartis AG Description and Business Overview

Table 132. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Novartis AG Intranasal Drug Delivery System Product

Table 134. Novartis AG Recent Development

Table 135. Vectura Group Plc Company Information

Table 136. Vectura Group Plc Description and Business Overview

Table 137. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Vectura Group Plc Intranasal Drug Delivery System Product

Table 139. Vectura Group Plc Recent Development

Table 140. Production Base and Market Concentration Rate of Raw Material

Table 141. Key Suppliers of Raw Materials

Table 142. Intranasal Drug Delivery System Distributors List

Table 143. Intranasal Drug Delivery System Customers List

Table 144. Intranasal Drug Delivery System Market Trends

Table 145. Intranasal Drug Delivery System Market Drivers

Table 146. Intranasal Drug Delivery System Market Challenges

Table 147. Intranasal Drug Delivery System Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Intranasal Drug Delivery System Product Picture

Figure 2. Global Intranasal Drug Delivery System Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Intranasal Drug Delivery System Sales Market Share by Type in 2024 & 2031

Figure 4. Nasal Drops Product Picture

Figure 5. Nasal Sprays Product Picture

Figure 6. Nasal Gels Product Picture

Figure 7. Nasal Suspensions and Emulsion Product Picture

Figure 8. Nasal Powders Product Picture

Figure 9. Global Intranasal Drug Delivery System Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 10. Global Intranasal Drug Delivery System Sales Market Share by Application in 2024 & 2031

Figure 11. Hospital Examples

Figure 12. Clinic Examples

Figure 13. Home Care Examples

Figure 14. Others Examples

Figure 15. Global Intranasal Drug Delivery System Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Intranasal Drug Delivery System Sales Growth Rate (2020-2031) & (US$ Million)

Figure 17. Global Intranasal Drug Delivery System Sales (K Units) Growth Rate (2020-2031)

Figure 18. Global Intranasal Drug Delivery System Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 19. Intranasal Drug Delivery System Report Years Considered

Figure 20. Global Market Intranasal Drug Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 21. Global Intranasal Drug Delivery System Revenue Market Share by Region: 2020 VS 2024

Figure 22. North America Intranasal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. North America Intranasal Drug Delivery System Sales (K Units) Growth Rate (2020-2031)

Figure 24. Europe Intranasal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Europe Intranasal Drug Delivery System Sales (K Units) Growth Rate (2020-2031)

Figure 26. China Intranasal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. China Intranasal Drug Delivery System Sales (K Units) Growth Rate (2020-2031)

Figure 28. Japan Intranasal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan Intranasal Drug Delivery System Sales (K Units) Growth Rate (2020-2031)

Figure 30. Global Intranasal Drug Delivery System Revenue Share by Type (2020-2025)

Figure 31. Global Intranasal Drug Delivery System Sales Share by Type (2026-2031)

Figure 32. Global Intranasal Drug Delivery System Revenue Share by Type (2026-2031)

Figure 33. Global Intranasal Drug Delivery System Revenue Share by Application (2020-2025)

Figure 34. Global Intranasal Drug Delivery System Revenue Growth Rate by Application in 2020 & 2024

Figure 35. Global Intranasal Drug Delivery System Sales Share by Application (2026-2031)

Figure 36. Global Intranasal Drug Delivery System Revenue Share by Application (2026-2031)

Figure 37. Global Intranasal Drug Delivery System Sales Share by Company (2024)

Figure 38. Global Intranasal Drug Delivery System Revenue Share by Company (2024)

Figure 39. Global 5 Largest Intranasal Drug Delivery System Players Market Share by Revenue in Intranasal Drug Delivery System: 2020 & 2024

Figure 40. Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 41. Manufacturing Cost Structure of Intranasal Drug Delivery System

Figure 42. Manufacturing Process Analysis of Intranasal Drug Delivery System

Figure 43. Intranasal Drug Delivery System Industrial Chain

Figure 44. Channels of Distribution (Direct Vs Distribution)

Figure 45. Distributors Profiles

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

目次

This research report focuses on the Intranasal Drug Delivery System Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Intranasal Drug Delivery System Product Scope
  • 1.2 Intranasal Drug Delivery System by Type
    • 1.2.1 Global Intranasal Drug Delivery System Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Nasal Drops
    • 1.2.3 Nasal Sprays
    • 1.2.4 Nasal Gels
    • 1.2.5 Nasal Suspensions and Emulsion
    • 1.2.6 Nasal Powders
  • 1.3 Intranasal Drug Delivery System by Application
    • 1.3.1 Global Intranasal Drug Delivery System Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Home Care
    • 1.3.5 Others
  • 1.4 Global Intranasal Drug Delivery System Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Intranasal Drug Delivery System Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Intranasal Drug Delivery System Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Intranasal Drug Delivery System Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Intranasal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Intranasal Drug Delivery System Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Intranasal Drug Delivery System Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Intranasal Drug Delivery System Revenue Market Share by Region (2020-2025)
  • 2.3 Global Intranasal Drug Delivery System Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Intranasal Drug Delivery System Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Intranasal Drug Delivery System Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Intranasal Drug Delivery System Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Intranasal Drug Delivery System Market Size and Prospective (2020-2031)
    • 2.4.3 China Intranasal Drug Delivery System Market Size and Prospective (2020-2031)
    • 2.4.4 Japan Intranasal Drug Delivery System Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Intranasal Drug Delivery System Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Intranasal Drug Delivery System Sales by Type (2020-2025)
    • 3.1.2 Global Intranasal Drug Delivery System Revenue by Type (2020-2025)
    • 3.1.3 Global Intranasal Drug Delivery System Price by Type (2020-2025)
  • 3.2 Global Intranasal Drug Delivery System Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Intranasal Drug Delivery System Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Intranasal Drug Delivery System Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Intranasal Drug Delivery System Price Forecast by Type (2026-2031)
  • 3.3 Different Types Intranasal Drug Delivery System Representative Players

4 Global Market Size by Application

  • 4.1 Global Intranasal Drug Delivery System Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Intranasal Drug Delivery System Sales by Application (2020-2025)
    • 4.1.2 Global Intranasal Drug Delivery System Revenue by Application (2020-2025)
    • 4.1.3 Global Intranasal Drug Delivery System Price by Application (2020-2025)
  • 4.2 Global Intranasal Drug Delivery System Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Intranasal Drug Delivery System Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Intranasal Drug Delivery System Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Intranasal Drug Delivery System Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Intranasal Drug Delivery System Application

5 Competition Landscape by Players

  • 5.1 Global Intranasal Drug Delivery System Sales by Players (2020-2025)
  • 5.2 Global Top Intranasal Drug Delivery System Players by Revenue (2020-2025)
  • 5.3 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2024)
  • 5.4 Global Intranasal Drug Delivery System Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Intranasal Drug Delivery System, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Intranasal Drug Delivery System, Product Type & Application
  • 5.7 Global Key Manufacturers of Intranasal Drug Delivery System, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Intranasal Drug Delivery System Sales by Company
      • 6.1.1.1 North America Intranasal Drug Delivery System Sales by Company (2020-2025)
      • 6.1.1.2 North America Intranasal Drug Delivery System Revenue by Company (2020-2025)
    • 6.1.2 North America Intranasal Drug Delivery System Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Intranasal Drug Delivery System Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Intranasal Drug Delivery System Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Intranasal Drug Delivery System Sales by Company
      • 6.2.1.1 Europe Intranasal Drug Delivery System Sales by Company (2020-2025)
      • 6.2.1.2 Europe Intranasal Drug Delivery System Revenue by Company (2020-2025)
    • 6.2.2 Europe Intranasal Drug Delivery System Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Intranasal Drug Delivery System Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Intranasal Drug Delivery System Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 China Intranasal Drug Delivery System Sales by Company
      • 6.3.1.1 China Intranasal Drug Delivery System Sales by Company (2020-2025)
      • 6.3.1.2 China Intranasal Drug Delivery System Revenue by Company (2020-2025)
    • 6.3.2 China Intranasal Drug Delivery System Sales Breakdown by Type (2020-2025)
    • 6.3.3 China Intranasal Drug Delivery System Sales Breakdown by Application (2020-2025)
    • 6.3.4 China Intranasal Drug Delivery System Major Customer
    • 6.3.5 China Market Trend and Opportunities
  • 6.4 Japan Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 Japan Intranasal Drug Delivery System Sales by Company
      • 6.4.1.1 Japan Intranasal Drug Delivery System Sales by Company (2020-2025)
      • 6.4.1.2 Japan Intranasal Drug Delivery System Revenue by Company (2020-2025)
    • 6.4.2 Japan Intranasal Drug Delivery System Sales Breakdown by Type (2020-2025)
    • 6.4.3 Japan Intranasal Drug Delivery System Sales Breakdown by Application (2020-2025)
    • 6.4.4 Japan Intranasal Drug Delivery System Major Customer
    • 6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 Aptar Pharma
    • 7.1.1 Aptar Pharma Company Information
    • 7.1.2 Aptar Pharma Business Overview
    • 7.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 Aptar Pharma Intranasal Drug Delivery System Products Offered
    • 7.1.5 Aptar Pharma Recent Development
  • 7.2 Nemera
    • 7.2.1 Nemera Company Information
    • 7.2.2 Nemera Business Overview
    • 7.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Nemera Intranasal Drug Delivery System Products Offered
    • 7.2.5 Nemera Recent Development
  • 7.3 Teleflex
    • 7.3.1 Teleflex Company Information
    • 7.3.2 Teleflex Business Overview
    • 7.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Teleflex Intranasal Drug Delivery System Products Offered
    • 7.3.5 Teleflex Recent Development
  • 7.4 Bio-Legacy Evaluative Group
    • 7.4.1 Bio-Legacy Evaluative Group Company Information
    • 7.4.2 Bio-Legacy Evaluative Group Business Overview
    • 7.4.3 Bio-Legacy Evaluative Group Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 Bio-Legacy Evaluative Group Intranasal Drug Delivery System Products Offered
    • 7.4.5 Bio-Legacy Evaluative Group Recent Development
  • 7.5 Zeteo Medical
    • 7.5.1 Zeteo Medical Company Information
    • 7.5.2 Zeteo Medical Business Overview
    • 7.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 Zeteo Medical Intranasal Drug Delivery System Products Offered
    • 7.5.5 Zeteo Medical Recent Development
  • 7.6 Johnson & Johnson
    • 7.6.1 Johnson & Johnson Company Information
    • 7.6.2 Johnson & Johnson Business Overview
    • 7.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 Johnson & Johnson Intranasal Drug Delivery System Products Offered
    • 7.6.5 Johnson & Johnson Recent Development
  • 7.7 GlaxoSmithKline Plc
    • 7.7.1 GlaxoSmithKline Plc Company Information
    • 7.7.2 GlaxoSmithKline Plc Business Overview
    • 7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Products Offered
    • 7.7.5 GlaxoSmithKline Plc Recent Development
  • 7.8 Aegis Therapeutics LLC
    • 7.8.1 Aegis Therapeutics LLC Company Information
    • 7.8.2 Aegis Therapeutics LLC Business Overview
    • 7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Products Offered
    • 7.8.5 Aegis Therapeutics LLC Recent Development
  • 7.9 H&T Presspart Manufacturing Ltd.
    • 7.9.1 H&T Presspart Manufacturing Ltd. Company Information
    • 7.9.2 H&T Presspart Manufacturing Ltd. Business Overview
    • 7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Products Offered
    • 7.9.5 H&T Presspart Manufacturing Ltd. Recent Development
  • 7.10 AstraZeneca Plc
    • 7.10.1 AstraZeneca Plc Company Information
    • 7.10.2 AstraZeneca Plc Business Overview
    • 7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Products Offered
    • 7.10.5 AstraZeneca Plc Recent Development
  • 7.11 Becton
    • 7.11.1 Becton Company Information
    • 7.11.2 Becton Business Overview
    • 7.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.11.4 Becton Intranasal Drug Delivery System Products Offered
    • 7.11.5 Becton Recent Development
  • 7.12 BD
    • 7.12.1 BD Company Information
    • 7.12.2 BD Business Overview
    • 7.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.12.4 BD Intranasal Drug Delivery System Products Offered
    • 7.12.5 BD Recent Development
  • 7.13 Novartis AG
    • 7.13.1 Novartis AG Company Information
    • 7.13.2 Novartis AG Business Overview
    • 7.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.13.4 Novartis AG Intranasal Drug Delivery System Products Offered
    • 7.13.5 Novartis AG Recent Development
  • 7.14 Vectura Group Plc
    • 7.14.1 Vectura Group Plc Company Information
    • 7.14.2 Vectura Group Plc Business Overview
    • 7.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
    • 7.14.4 Vectura Group Plc Intranasal Drug Delivery System Products Offered
    • 7.14.5 Vectura Group Plc Recent Development

8 Intranasal Drug Delivery System Manufacturing Cost Analysis

  • 8.1 Intranasal Drug Delivery System Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Intranasal Drug Delivery System
  • 8.4 Intranasal Drug Delivery System Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Intranasal Drug Delivery System Distributors List
  • 9.3 Intranasal Drug Delivery System Customers

10 Intranasal Drug Delivery System Market Dynamics

  • 10.1 Intranasal Drug Delivery System Industry Trends
  • 10.2 Intranasal Drug Delivery System Market Drivers
  • 10.3 Intranasal Drug Delivery System Market Challenges
  • 10.4 Intranasal Drug Delivery System Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer